1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Prematurity: new trials by email Literature Review of Prematurity trials Research Report on Prematurity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. Poractant Alfa Intratracheal Suspension [Curosurf], Budesonide 0.5 MG/ML - Bronchopulmonary Dysplasia, Respiratory Distress Syndrome in Premature Infant | Phase 3 | Unknown | Hospital Clinic of Barcelona | 50 | 2021-10-01 | 2021-09-13 |
Bronchopulmonary Dysplasia (1) · Lung Injury (1) · Premature Birth (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Infant, Newborn, Diseases (1) · Infant, Premature, Diseases (1) · Lung Diseases (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1) · Respiratory Tract Diseases (1) · Thoracic Injuries (1) · Urogenital Diseases (1) · Ventilator-Induced Lung Injury (1) · Wounds and Injuries (1)
Budesonide (1) · poractant alfa (1)
Hospital Clinic of Barcelona (1)